MOUNTAIN VIEW, Calif. (August 26, 2008) – Conceptus, Inc. (NASDAQ: CPTS), announced today that Mark Sieczkarek, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, at 3:20 p.m. EDT. The conference will be held at the Grand Hyatt New York Hotel.

A live webcast of the presentation will be available by going to www.conceptus.com and clicking on the link to Live Webcasts. An archived replay will be available for a period of 30 days.

About the Essure Procedure

The Essure procedure is a permanent birth control method that can be done in the comfort of a physician's office in about 13 minutes(1) without hormones, cutting, burning or the risks associated with general anesthesia or tubal ligation. Small, flexible micro-inserts are placed in the woman's fallopian tubes through the cervix without incisions. Over the next three months, the body forms a natural barrier around the micro-inserts to prevent sperm from reaching the egg. Essure is 99.8 percent effective(2) with zero pregnancies reported in clinical trials.

Three months after the Essure procedure, a doctor can perform an Essure Confirmation Test to confirm that the fallopian tubes are fully blocked and that the patient can rely on Essure for permanent birth control with full confidence. Essure was FDA-approved in 2002 and more than 180,000 women worldwide have undergone the Essure procedure.

About Conceptus, Inc.

Conceptus, Inc. manufactures and markets the Essure Permanent Birth Control system, an innovative medical device and procedure designed to provide a non-incisional alternative to tubal ligation, which is currently the leading form of birth control worldwide. The availability of the Essure procedure in the U.S. is expected to open up a market currently occupied by incisional tubal ligation and vasectomy, which combined account for over 1 million procedures annually.

Additional information about the Essure procedure is available at www.essure.com or by calling the Essure Information Center at 1-877-ESSURE1. Additional information about Conceptus is available at www.conceptus.com or by calling 1-877-ESSURE2.

---

(1) Average hysteroscopic procedure time
(2) Based on 4 years of follow-up

Essure and Conceptus are registered trademarks of Conceptus Inc.